Tests a support program for high blood pressure in Black adults

Trial details

Who runs it

NYU Langone Health

Trial code

NCT05208450

Record updated

2 June 2026

Original description

To use practice facilitation (PF) + community health worker (CHW) facilitation as a practical and sustainable implementation strategy to support the implementation and evaluation of three multi-level evidence-based interventions [nurse case management (NCM), remote blood pressure monitoring (RBPM), and social determinants of health (SDOH) support] delivered as an integrated community-clinic linkage model [Practice support And Community Engagement (PACE) to address patient-, physician-, health system-, and community-level barriers to hypertension (HTN) control in Blacks across 25 primary practices within NYU Langone Health in New York City (NYC) and, in partnership with an established Community-Clinic-Academic Advisory Board and HealthFirst (NYC's largest Medicaid payer).Read full original descriptionShow less

Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks

To use practice facilitation (PF) + community health worker (CHW) facilitation as a practical and sustainable implementation strategy to support the implementation and evaluation of three multi-level evidence-based interventions [nurse case management (NCM), remote blood pressure monitoring (RBPM), and social determinants of health (SDOH) support] delivered as an integrated community-clinic linkage model [Practice support And Community Engagement (PACE) to address patient-, physician-, health system-, and community-level barriers to hypertension (HTN) control in Blacks across 25 primary practices within NYU Langone Health in New York City (NYC) and, in partnership with an established Community-Clinic-Academic Advisory Board and HealthFirst (NYC's largest Medicaid payer).

The goal for the UH3 Implementation Phase (Years 4-7, Intervention) is to evaluate a stepped-wedge cluster RCT of 25 primary care practices in Black patients with uncontrolled hypertension (HTN)

Inclusion: Patients are eligible if he/she:; identifies as Black (through EHR code or self-report); is 18+ years of age; has a diagnosis of HTN (identified by ICD-10 codes for HTN); prescribed an antihypertensive medication(s); has a clinic BP > 130/80 mmHg.

Exclusion: participate in other hypertension-related clinical trials; have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR); NYULH Primary care provider (MD/DO, NP), Clinical Director, Site Administrator, Medical Assistant, or administrative staff employed at the participating practices and interacts with at least five patients with a diagnosis of hypertension; or; Patients will be ineligible for the study if they:; are deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks); plan to discontinue care at the site within the next 12 months; or; are pregnant or planning to become pregnant in the next 12 months; IMPLEMENTATION EVALUATION; NYULH Nurse case manager within centralized service; or; Staff and leadership of community- and faith-based organizations serving the Black community; or; NYULH Organizational leadership; or; NYULH Project Staff: Community Health Workers/CHW Supervisor/Practice Facilitators; and; Able and willing to provide consent; Refusal to participate.

UH3 IMPLEMENTATION PHASE (Years 4 - 7): INTERVENTION.

ClinicalTrials.gov NCT05208450